Vanderbilt Heart and Vascular Institute Archives
VHVI reaches milestone in cardiac monitor implants
Sep. 15, 2021—Vanderbilt has reached a new milestone in implanting CardioMEMS remote cardiac monitoring devices.
VHVI offers latest therapies to treat atrial fibrillation
Sep. 9, 2021—Vanderbilt Heart and Vascular Institute continues to offer the latest in therapies to treat atrial fibrillation (AF or AFib), the most common cardiac arrhythmia.
Novel LVAD allows patient to see family, celebrate milestones
Sep. 2, 2021—Brandon Cochran, a 39-year-old real estate agent in Louisville, Kentucky, was at home with his family in October 2020 when he went into cardiac arrest. His implanted defibrillator shocked him back to life, and he was hospitalized for seven months.
Structural Heart and Valve Center reaches procedure milestones
Aug. 12, 2021—The Structural Heart and Valve Center at Vanderbilt Heart and Vascular Institute (VHVI) has recently completed multiple groundbreaking transcatheter clinical trial procedures treating severe regurgitation of the mitral and tricuspid valves, a continuation of a decade of research that is revolutionizing the treatment of these conditions.
Anticoagulation Clinic at Vanderbilt Heart designated an Anticoagulation Center of Excellence
Jun. 9, 2021—The Anticoagulation Clinic at Vanderbilt Heart and Vascular Institute (VHVI) has been designated an Anticoagulation Center of Excellence by the Anticoagulation Forum, one of only three in Tennessee.
New Clinician Spotlight: Matthews Chacko
Apr. 8, 2021—Matthews Chacko, MD, has joined Vanderbilt Heart and Vascular Institute as an assistant professor of Medicine, an interventional cardiologist and the director of peripheral vascular interventions.
Murfreesboro heart clinic reveals power of diversity
Mar. 10, 2021—In suburban Murfreesboro, just a short drive off Interstate 24, is one of the most diverse practices and clinics in Vanderbilt Health.
Congenital Heart Program gains accreditation from ACHA
Jan. 21, 2021—The Adult Congenital Heart Association (ACHA) has awarded the Vanderbilt Adult Congenital Heart Program status as an Adult Congenital Heart Disease (ACHD) Accredited Comprehensive Care Center — the first in Tennessee.
Freedman named director of the Division of Cardiovascular Medicine
Jan. 7, 2021—Jane Freedman, MD, will join Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and the physician-in-chief of the Vanderbilt Heart and Vascular Institute, effective Aug. 1.
Muñoz named to key VHVI leadership role
Dec. 17, 2020—Daniel Muñoz, MD, MPA, associate professor of Medicine, has been named the new executive medical director of the Patient Care Center (PCC) at Vanderbilt Heart and Vascular Institute (VHVI), effective Jan. 1, 2021.
VHVI’s Brown, Agrawal receive American Heart Association awards
Dec. 10, 2020—Two Vanderbilt Heart and Vascular Institute researchers are receiving awards from the American Heart Association.
Minimally invasive treatment option for AFib studied
Oct. 22, 2020—A minimally invasive procedure that combines ligation of the left atrial appendage (LAA) with hybrid epicardial-endocardial ablation is a feasible, safe and effective method of treating patients with longstanding atrial fibrillation (AF or AFib), according to a new Vanderbilt-led study.